- Previous Rank709
- Revenues ($M)3,647
- Revenue Percent Change16.7%
- Profits ($M)165
- Profits Percent Change-
- Market Value (as of March 31, 2015)-
Company Info
CEO | Brenton L. Saunders |
Industry | Pharmaceuticals |
Sector | Health Care |
HQ Location | New York, NY |
Website | http://www.actavis.com |
Years on List | - |
Key Financials (last fiscal year)
$ millions | % change | |
---|---|---|
Revenues ($M) | 3,647 | 16.7% |
Profits ($M) | 165 | - |
Total Stockholder Equity | 6,166 | - |
Employees | 6,200 | - |
Market Value (as of March 31, 2015) | - | - |
Profit Ratios
Profit as % of Revenues | 4.5% |
Profits as % of Assets | 1.4% |
Profits as % of Stockholder Equity | 2.7% |
Earnings Per Share (last fiscal year)
Earnings Per Share ($) | 0.61 |
EPS % Change (from 2013) | - |
EPS % Change (5 year annual rate) | -24.7% |
EPS % Change (10 year annual rate) | -11% |
Total Return
Total Return to Investors (2014) | - |
Total Return to Investors (5 year, annualized) | - |
Total Return to Investors (10 year, annualized) | - |